カテゴリー： visiongain, 世界, 医療/バイオ

治験用品の世界市場2023〜2033

◆英語タイトル：Clinical Trial Supplies Market Report 2023-2033 : Forecasts by Location (Offshore Clinical Site, Domestic Clinical Site), by Type (Small Molecule Products, Biologic Products, Medical Devices), by Services (Manufacturing (IMPs and INDs, Placebos, Assays and Test Kits, Others), Logistics & Distribution (Cold Chain Distribution, Non-cold Chain), Storage & Retention, Packaging and Labelling, Comparator Sourcing, Other), by Therapeutic Areas (Oncology, CNS and Mental Disorders, Cardiovascular Disease (CVD), Infectious Disease, Immunology Disease, Blood Disorders, Metabolic Disorders, Digestive Disorders, Other), by Phase (Phase-I, Phase-II, Phase-III, Phase-IV), by End-user (Contract Research Organisations, Pharmaceutical and Biotechnology Companies, Medical Device Companies, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

visiongainが発行した調査報告書（VGA23FB005）◆商品コード：VGA23FB005
◆発行会社（リサーチ会社）：visiongain
◆発行日：2023年1月31日
◆ページ数：423
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Sigle User（1名様閲覧用、1年間、印刷不可）GBP3,950 ⇒換算￥750,500見積依頼/購入/質問フォーム
Enterprise（法人閲覧用、1年間、印刷可）GBP6,950 ⇒換算￥1,320,500見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM（デジタル著作権管理）付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Visiongain社の市場調査によると、世界の治験用品市場規模が2033年までに年平均9.32%で成長すると予測されます。本書は、治験用品の世界市場について調査・分析し、レポート概要、エグゼクティブサマリー、市場動向、種類別（低分子製品、バイオ製品、医療機器）分析、サービス別（製造、物流＆流通、貯蔵、包装＆ラベリング、その他）分析、治療領域別（腫瘍、中枢神経系＆精神障害、心血管疾患（CVD）、感染症、その他）分析、フェーズ別（フェーズI、フェーズII、フェーズIII、フェーズIV）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、企業情報などの項目を掲載しています。また、企業情報として、ADAllen Pharma、AmerisourceBergen Corporation、Ancillare、Biocair、Catalent, Inc.、Clinigen Group plc、Coghlan Group、COREX Logistics、DHL、Durbin、Endpoint Clinical、Eurofins Scientific SE、Inizio (UDG Healthcare plc)、IQVIA Inc.、KLIFOなどが含まれています。
・レポート概要
・エグゼクティブサマリー
・市場動向
・世界の治験用品市場規模：種類別
- 低分子製品の市場規模
- バイオ製品の市場規模
- 医療機器の市場規模
・世界の治験用品市場規模：サービス別
- 製造サービスにおける市場規模
- 物流＆流通サービスにおける市場規模
- 貯蔵サービスにおける市場規模
- 包装＆ラベリングサービスにおける市場規模
- その他サービスにおける市場規模
・世界の治験用品市場規模：治療領域別
- 腫瘍における市場規模
- 中枢神経系＆精神障害における市場規模
- 心血管疾患（CVD）における市場規模
- 感染症における市場規模
- その他治療における市場規模
・世界の治験用品市場規模：フェーズ別
- フェーズI治験用品の市場規模
- フェーズII治験用品の市場規模
- フェーズIII治験用品の市場規模
- フェーズIV治験用品の市場規模
・世界の治験用品市場規模：地域別
- 北米の治験用品市場規模
- ヨーロッパの治験用品市場規模
- アジア太平洋の治験用品市場規模
- 中南米の治験用品市場規模
- 中東・アフリカの治験用品市場規模
・企業情報

The Clinical Trial Supplies Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Demand for Clinical Trial Outsourcing is driving the Demand for Clinical Trial Supplies Market
Downsizing and cost-cutting are important factors for large and mid-size pharmaceutical companies to outsource clinical trials, as CRO expertise in a specific therapeutic in a market where the company lacks experience with regulatory processes, operational expertise, and the ability to use manpower for other activities at the time of increasing workload. Furthermore, due to the increasing process complexity and cost of clinical studies, pharmaceutical manufacturers have been forced to outsource clinical trial supplies and supply them to research sites for reducing cost and time. Clinical supply firms are concentrating on data sharing to assist them build a solid supply chain for clinical consumables during clinical trials. This factor will have a favourable impact on the revenue growth of the clinical trial supplies market throughout the forecast period.

Unavailability of Storage Facilities in across Multiple Nations May Hamper the Expansion Clinical Trial Supplies Market
Certain clinical materials must be stored under specific climatic conditions, and such facilities are critical before conducting clinical studies. However, in countries such as Mexico, Brazil, and others, lack of clinical supply storage facilities and infrastructure may impede market acceptance of clinical trial supplies services. It is critical, for example, to determine early on if important components of the cold chain must be held in controlled temperature facilities if things are stored. Transportation of clinical supplies from cold storage to clinical sites is difficult, which is projected to limit revenue growth in this market to some extent.

What Questions Should You Ask before Buying a Market Research Report?
• How is the clinical trial supplies market evolving?
• What is driving and restraining the clinical trial supplies market?
• How will each clinical trial supplies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each clinical trial supplies submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading clinical trial supplies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the clinical trial supplies projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of clinical trial supplies projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the clinical trial supplies market?
• Where is the clinical trial supplies market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial supplies market today, and over the next 10 years:
• Our 423-page report provides 187 tables and 272 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trial supplies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial supplies prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Location
• Offshore Clinical Site
• Domestic Clinical Site

Type
• Small Molecule Products
• Biologic Products
• Medical Devices

Services
• Manufacturing
– IMPs and INDs
– Placebos
– Assays and Testkits
– Others
• Logistics & Distribution
– Cold Chain Distribution
– Non-cold Chain
• Storage & Retention
• Packaging and Labeling
• Comparator Sourcing
• Other CTS Services

Therapeutic Areas
• Oncology
• CNS and Mental Disorders
• Cardiovascular Disease (CVD)
• Infectious Disease
• Immunology Disease
• Blood Disorders
• Metabolic Disorders
• Digestive Disorders
• Other Therapeutic Areas

Phase
• Phase-I
• Phase-II
• Phase-III
• Phase-IV

End-User
• Contract Research Organizations
• Pharmaceutical and Biotechnology Companies
• Medical Device Companies
• Other End-Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 23 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• South Africa
• Saudi Arabia
• Turkey
• UAE
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trial Supplies Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• ADAllen Pharma
• AmerisourceBergen Corporation
• Ancillare
• Biocair
• Catalent, Inc.
• Clinigen Group plc
• Coghlan Group
• COREX Logistics
• DHL
• Durbin
• Endpoint Clinical
• Eurofins Scientific SE
• Inizio (UDG Healthcare plc)
• IQVIA Inc.
• KLIFO
• Liveo Research
• Lonza
• Marken (A UPS Company)
• Movianto
• Myonex
• N-SIDE
• Parexel
• PCI Pharma Services
• Piramal Pharma Solutions
• Recipharm AB
• Rubicon Research Pvt S.A.
• Seveillar Clinical Supplies Services
• Sharp Corporation
• SIRO Clinpharm
• Thermo Fisher Scientific Inc.

Overall world revenue for Clinical Trial Supplies Market, 2023 to 2033 in terms of value the market will surpass US$ 2,819.2 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Clinical Trial Supplies Market, 2023 to 2033 report help you?
In summary, our 420+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Clinical Trial Supplies Market, 2023 to 2033, with forecasts for location, type, services, therapeutic areas, phase, and end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 19 key national markets – See forecasts for the Clinical Trial Supplies Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 30 of the major companies involved in the Clinical Trial Supplies Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Clinical Trial Supplies Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

❖ レポートの目次 ❖

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Clinical Trial Supplies Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Demand for Clinical Trial Outsourcing
3.2.1.2 Rising Demand for Biologics Propelling Growth of Cold Chain Supplies
3.2.1.3 Increasing Investments in the Development of Novel Pharmaceuticals
3.2.1.4 Technology Advancements are Propelling Market Expansion
3.2.2 Market Restraining
3.2.2.1 Availability of Storage Facilities in Each Country
3.2.2.2 Lack of Comparator Sourcing
3.2.2.3 High Costs Associated with Drug Developments
3.2.3 Market Opportunities
3.2.3.1 Increasing Opportunities for Emerging Markets
3.2.3.2 Cut in High Costs Expected to Propel Market Growth
3.2.3.3 Integration of Technical Solutions
3.3 COVID-19 Impact Analysis
3.4 PEST Analysis
3.4.1 Political Factors
3.4.2 Economic Factors
3.4.3 Social Factors
3.4.4 Technological Factors

4 Clinical Trial Supplies Market Analysis by Location
4.1 Key Findings
4.2 Location Segment: Market Attractiveness Index
4.3 Clinical Trial Supplies Market Size Estimation and Forecast by Location
4.4 Offshore Clinical Site
4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Domestic Clinical Site
4.5.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Clinical Trial Supplies Market Analysis by Type
5.1 Key Findings
5.2 Type Segment: Market Attractiveness Index
5.3 Clinical Trial Supplies Market Size Estimation and Forecast by Type
5.4 Small Molecule Products
5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Biologic Products
5.5.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Medical Devices
5.6.1 Market Size by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Clinical Trial Supplies Market Analysis by Services
6.1 Key Findings
6.2 Services Segment: Market Attractiveness Index
6.3 Clinical Trial Supplies Market Size Estimation and Forecast by Services
6.4 Manufacturing
6.4.1 Market Size by Region, 2023-2033 (US$ Mn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.4.3 IMPs and INDs
6.4.4 Market Size by Region, 2023-2033 (US$ Mn)
6.4.5 Market Share by Region, 2023 & 2033 (%)
6.4.6 Placebos
6.4.7 Market Size by Region, 2023-2033 (US$ Mn)
6.4.8 Market Share by Region, 2023 & 2033 (%)
6.4.9 Assays and Test kits
6.4.10 Market Size by Region, 2023-2033 (US$ Mn)
6.4.11 Market Share by Region, 2023 & 2033 (%)
6.4.12 Others
6.4.13 Market Size by Region, 2023-2033 (US$ Mn)
6.4.14 Market Share by Region, 2023 & 2033 (%)
6.5 Logistics & Distribution
6.5.1 Market Size by Region, 2023-2033 (US$ Mn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.5.3 Cold Chain Distribution
6.5.4 Market Size by Region, 2023-2033 (US$ Mn)
6.5.5 Market Share by Region, 2023 & 2033 (%)
6.5.6 Non-cold Chain
6.5.7 Market Size by Region, 2023-2033 (US$ Mn)
6.5.8 Market Share by Region, 2023 & 2033 (%)
6.6 Storage & Retention
6.6.1 Market Size by Region, 2023-2033 (US$ Mn)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Packaging and Labelling
6.7.1 Market Size by Region, 2023-2033 (US$ Mn)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Comparator Sourcing
6.8.1 Market Size by Region, 2023-2033 (US$ Mn)
6.8.2 Market Share by Region, 2023 & 2033 (%)
6.9 Other CTS Services
6.9.1 Market Size by Region, 2023-2033 (US$ Mn)
6.9.2 Market Share by Region, 2023 & 2033 (%)

7 Clinical Trial Supplies Market Analysis by Therapeutic Areas
7.1 Key Findings
7.2 Therapeutic Areas Segment: Market Attractiveness Index
7.3 Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
7.4 Oncology
7.4.1 Market Size by Region, 2023-2033 (US$ Mn)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 CNS and Mental Disorders
7.5.1 Market Size by Region, 2023-2033 (US$ Mn)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Cardiovascular Disease (CVD)
7.6.1 Market Size by Region, 2023-2033 (US$ Mn)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Infectious Disease
7.7.1 Market Size by Region, 2023-2033 (US$ Mn)
7.7.2 Market Share by Region, 2023 & 2033 (%)
7.8 Immunological Diseases
7.8.1 Market Size by Region, 2023-2033 (US$ Mn)
7.8.2 Market Share by Region, 2023 & 2033 (%)
7.9 Blood Disorders
7.9.1 Market Size by Region, 2023-2033 (US$ Mn)
7.9.2 Market Share by Region, 2023 & 2033 (%)
7.10 Metabolic Disorders
7.10.1 Market Size by Region, 2023-2033 (US$ Mn)
7.10.2 Market Share by Region, 2023 & 2033 (%)
7.11 Digestive Disorders
7.11.1 Market Size by Region, 2023-2033 (US$ Mn)
7.11.2 Market Share by Region, 2023 & 2033 (%)
7.12 Other Therapeutic Areas
7.12.1 Market Size by Region, 2023-2033 (US$ Mn)
7.12.2 Market Share by Region, 2023 & 2033 (%)

8 Clinical Trial Supplies Market Analysis by Phase
8.1 Key Findings
8.2 Phase Segment: Market Attractiveness Index
8.3 Clinical Trial Supplies Market Size Estimation and Forecast by Phase
8.4 Phase-I
8.4.1 Market Size by Region, 2023-2033 (US$ Mn)
8.4.2 Market Share by Region, 2023 & 2033 (%)
8.5 Phase-II
8.5.1 Market Size by Region, 2023-2033 (US$ Mn)
8.5.2 Market Share by Region, 2023 & 2033 (%)
8.6 Phase-III
8.6.1 Market Size by Region, 2023-2033 (US$ Mn)
8.6.2 Market Share by Region, 2023 & 2033 (%)
8.7 Phase-IV
8.7.1 Market Size by Region, 2023-2033 (US$ Mn)
8.7.2 Market Share by Region, 2023 & 2033 (%)

9 Clinical Trial Supplies Market Analysis by End-User
9.1 Key Findings
9.2 End-User Segment: Market Attractiveness Index
9.3 Clinical Trial Supplies Market Size Estimation and Forecast by End-User
9.4 Contract Research Organizations
9.4.1 Market Size by Region, 2023-2033 (US$ Mn)
9.4.2 Market Share by Region, 2023 & 2033 (%)
9.5 Pharmaceutical and Biotechnology Companies
9.5.1 Market Size by Region, 2023-2033 (US$ Mn)
9.5.2 Market Share by Region, 2023 & 2033 (%)
9.6 Medical Device Companies
9.6.1 Market Size by Region, 2023-2033 (US$ Mn)
9.6.2 Market Share by Region, 2023 & 2033 (%)
9.7 Other End-Users
9.7.1 Market Size by Region, 2023-2033 (US$ Mn)
9.7.2 Market Share by Region, 2023 & 2033 (%)

10 Clinical Trial Supplies Market Analysis by Region
10.1 Key Findings
10.2 Regional Market Size Estimation and Forecast

11 North America Clinical Trial Supplies Market Analysis
11.1 Key Findings
11.2 North America Clinical Trial Supplies Market Attractiveness Index
11.3 North America Clinical Trial Supplies Market by Country, 2023, 2028 & 2033 (US$ bn)
11.4 North America Clinical Trial Supplies Market Size Estimation and Forecast by Country
11.5 North America Clinical Trial Supplies Market Size Estimation and Forecast by Location
11.6 North America Clinical Trial Supplies Market Size Estimation and Forecast by Type
11.7 North America Clinical Trial Supplies Market Size Estimation and Forecast by Services
11.7.1 North America Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing
11.7.2 North America Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution
11.8 North America Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
11.9 North America Clinical Trial Supplies Market Size Estimation and Forecast by Phase
11.10 North America Clinical Trial Supplies Market Size Estimation and Forecast by End-User
11.11 U.S. Clinical Trial Supplies Market Analysis
11.12 Canada Clinical Trial Supplies Market Analysis

12 Europe Clinical Trial Supplies Market Analysis
12.1 Key Findings
12.2 Europe Clinical Trial Supplies Market Attractiveness Index
12.3 Europe Clinical Trial Supplies Market by Country, 2023, 2028 & 2033 (US$ bn)
12.4 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Country
12.5 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Location
12.6 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Type
12.7 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Services
12.7.1 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing
12.7.2 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution
12.8 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
12.9 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Phase
12.10 Europe Clinical Trial Supplies Market Size Estimation and Forecast by End-User
12.11 Germany Clinical Trial Supplies Market Analysis
12.12 UK Clinical Trial Supplies Market Analysis
12.13 France Clinical Trial Supplies Market Analysis
12.14 Italy Clinical Trial Supplies Market Analysis
12.15 Spain Clinical Trial Supplies Market Analysis
12.16 Russia Clinical Trial Supplies Market Analysis
12.17 Rest of Europe Clinical Trial Supplies Market Analysis

13 Asia Pacific Clinical Trial Supplies Market Analysis
13.1 Key Findings
13.2 Asia Pacific Clinical Trial Supplies Market Attractiveness Index
13.3 Asia Pacific Clinical Trial Supplies Market by Country, 2023, 2028 & 2033 (US$ bn)
13.4 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Country
13.5 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Location
13.6 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Type
13.7 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Services
13.7.1 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing
13.7.2 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution
13.8 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
13.9 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Phase
13.10 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by End-User
13.11 China Clinical Trial Supplies Market Analysis
13.12 India Clinical Trial Supplies Market Analysis
13.13 Japan Clinical Trial Supplies Market Analysis
13.14 South Korea Clinical Trial Supplies Market Analysis
13.15 Australia Clinical Trial Supplies Market Analysis
13.16 Rest of Asia-Pacific Clinical Trial Supplies Market Analysis

14 Latin America Clinical Trial Supplies Market Analysis
14.1 Key Findings
14.2 Latin America Clinical Trial Supplies Market Attractiveness Index
14.3 Latin America Clinical Trial Supplies Market by Country, 2023, 2028 & 2033 (US$ bn)
14.4 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Country
14.5 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Location
14.6 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Type
14.7 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Services
14.7.1 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing
14.7.2 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution
14.8 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
14.9 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Phase
14.10 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by End-User
14.11 Brazil Clinical Trial Supplies Market Analysis
14.12 Mexico Clinical Trial Supplies Market Analysis
14.13 Rest of Latin America Clinical Trial Supplies Market Analysis

15 MEA Clinical Trial Supplies Market Analysis
15.1 Key Findings
15.2 MEA Clinical Trial Supplies Market Attractiveness Index
15.3 MEA Clinical Trial Supplies Market by Country, 2023, 2028 & 2033 (US$ bn)
15.4 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Country
15.5 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Location
15.6 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Type
15.7 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Services
15.7.1 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing
15.7.2 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution
15.8 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
15.9 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Phase
15.10 MEA Clinical Trial Supplies Market Size Estimation and Forecast by End-User
15.11 South Africa Clinical Trial Supplies Market Analysis
15.12 Saudi Arabia Clinical Trial Supplies Market Analysis
15.13 Turkey Clinical Trial Supplies Market Analysis
15.14 UAE Clinical Trial Supplies Market Analysis
15.15 Rest of MEA Clinical Trial Supplies Market Analysis

16 Company Profiles
16.1 Competitive Landscape, 2021
16.2 Strategic Outlook
16.3 Thermo Fisher Scientific Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.3.1 Net Revenue, 2017-2021
16.3.3.2 R&D, 2017-2021
16.3.3.3 Gross Profit, 2017-2021
16.3.3.4 Regional Market Shares, 2021
16.3.4 Product Benchmarking
16.3.5 Strategic Outlook
16.4 Catalent, Inc.
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.3.1 Net Revenue, 2017-2021
16.4.3.2 EBITDA, 2017-2021
16.4.3.3 Net Income, 2017-2021
16.4.3.4 Regional Market Shares, 2021
16.4.4 Product Benchmarking
16.4.5 Strategic Outlook
16.5 Piramal Pharma Solutions
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Product Benchmarking
16.5.4 Strategic Outlook
16.6 Eurofins Scientific SE
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.3.1 Net Revenue, 2017-2021
16.6.3.2 Operating Income, 2017-2021
16.6.3.3 EBITDA, 2017-2021
16.6.3.4 Net Income, 2017-2021
16.6.3.5 Regional Market Shares, 2021
16.6.4 Product Benchmarking
16.7 Lonza
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.3.1 Net Revenue, 2017-2021
16.7.3.2 EBIT, 2017-2021
16.7.3.3 Gross Profit, 2017-2021
16.7.4 Product Benchmarking
16.7.5 Strategic Outlook
16.8 Clinigen Group plc
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.3.1 Net Revenue, 2017-2021
16.8.3.2 EBITDA, 2017-2021
16.8.3.3 Net Income, 2017-2021
16.8.4 Product Benchmarking
16.8.5 Strategic Outlook
16.9 AmerisourceBergen Corporation
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.3.1 Net Revenue, 2017-2021
16.9.3.2 Operating Income, 2017-2021
16.9.3.3 EBITDA, 2017-2021
16.9.3.4 Net Income, 2017-2021
16.9.4 Product Benchmarking
16.9.5 Strategic Outlook
16.10 DHL
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.3.1 Net Revenue, 2017-2021
16.10.3.2 EBITDA, 2017-2021
16.10.3.3 Gross Profit, 2017-2021
16.10.3.4 Net Income, 2017-2021
16.10.3.5 Operating Income, 2017-2021
16.10.3.6 Regional Market Share, 2017-2021
16.10.4 Product Benchmarking
16.10.5 Strategic Outlook
16.11 Sharp Corporation
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.3.1 Net Revenue, 2017-2021
16.11.3.2 EBITDA, 2017-2021
16.11.3.3 Net Income, 2017-2021
16.11.3.4 Operating Income, 2017-2021
16.11.3.5 Gross Profit, 2017-2021
16.11.4 Product Benchmarking
16.11.5 Strategic Outlook
16.12 IQVIA Inc.
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Financial Analysis
16.12.3.1 Net Revenue, 2017-2021
16.12.3.2 EBITDA, 2017-2021
16.12.3.3 Gross Profit, 2017-2021
16.12.3.4 Net Income, 2017-2021
16.12.3.5 Operating Income, 2017-2021
16.12.3.6 Regional Market Share, 2017-2021
16.12.4 Product Benchmarking
16.12.5 Strategic Outlook
16.13 Parexel
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Product Benchmarking
16.13.4 Strategic Outlook
16.14 Biocair
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Product Benchmarking
16.14.4 Strategic Outlook
16.15 Liveo Research
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Product Benchmarking
16.15.4 Strategic Outlook
16.16 Marken (A UPS Company)
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Product Benchmarking
16.16.4 Strategic Outlook
16.17 PCI Pharma Services
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Product Benchmarking
16.17.4 Strategic Outlook
16.18 Ancillare
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Product Benchmarking
16.18.4 Strategic Outlook
16.19 N-SIDE
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Product Benchmarking
16.19.4 Strategic Outlook
16.20 Rubicon Research Pvt S.A.
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Product Benchmarking
16.20.4 Strategic Outlook
16.21 Myonex
16.21.1 Company Snapshot
16.21.2 Company Overview
16.21.3 Product Benchmarking
16.21.4 Strategic Outlook
16.22 Endpoint Clinical
16.22.1 Company Snapshot
16.22.2 Company Overview
16.22.3 Product Benchmarking
16.22.4 Strategic Outlook
16.23 Recipharm AB
16.23.1 Company Snapshot
16.23.2 Company Overview
16.23.3 Product Benchmarking
16.23.4 Strategic Outlook
16.24 COREX Logistics
16.24.1 Company Snapshot
16.24.2 Company Overview
16.24.3 Product Benchmarking
16.25 Movianto
16.25.1 Company Snapshot
16.25.2 Company Overview
16.25.3 Product Benchmarking
16.26 Durbin
16.26.1 Company Snapshot
16.26.2 Company Overview
16.26.3 Product Benchmarking
16.27 SIRO Clinpharm
16.27.1 Company Snapshot
16.27.2 Company Overview
16.27.3 Product Benchmarking
16.28 Inizio (UDG Healthcare plc)
16.28.1 Company Snapshot
16.28.2 Company Overview
16.28.3 Product Benchmarking
16.29 KLIFO
16.29.1 Company Snapshot
16.29.2 Company Overview
16.29.3 Product Benchmarking
16.30 ADAllen Pharma
16.30.1 Company Snapshot
16.30.2 Company Overview
16.30.3 Product Benchmarking
16.31 Seveillar Clinical Supplies Services
16.31.1 Company Snapshot
16.31.2 Company Overview
16.31.3 Product Benchmarking
16.32 Coghlan Group
16.32.1 Company Snapshot
16.32.2 Company Overview
16.32.3 Product Benchmarking
16.32.4 Strategic Outlook

17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players
17.2.1 Know Your Contract
17.2.2 Establish Clear Roles And Responsibilities
17.2.3 Create A Symbiotic Relationship



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 治験用品の世界市場2023〜2033(Clinical Trial Supplies Market Report 2023-2033 : Forecasts by Location (Offshore Clinical Site, Domestic Clinical Site), by Type (Small Molecule Products, Biologic Products, Medical Devices), by Services (Manufacturing (IMPs and INDs, Placebos, Assays and Test Kits, Others), Logistics & Distribution (Cold Chain Distribution, Non-cold Chain), Storage & Retention, Packaging and Labelling, Comparator Sourcing, Other), by Therapeutic Areas (Oncology, CNS and Mental Disorders, Cardiovascular Disease (CVD), Infectious Disease, Immunology Disease, Blood Disorders, Metabolic Disorders, Digestive Disorders, Other), by Phase (Phase-I, Phase-II, Phase-III, Phase-IV), by End-user (Contract Research Organisations, Pharmaceutical and Biotechnology Companies, Medical Device Companies, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 臨床試験用画像の世界市場2023年〜2033年
  • 心血管装置の世界市場2023〜2033
  • ニューロテックデバイスの世界市場2023〜2033
  • バイオディフェンスの世界市場2023〜2033
  • PoC診断の世界市場2023〜2033

    • ◆H&Iグローバルリサーチのお客様（例）◆